Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Alcon
ALC
$35.5B
| $753K | ﹤0.01% |
9,361
| – | – |
|
3827
Lantronix
LTRX
$272M
| $753K | ﹤0.01% |
129,518
+5,044
| +4% | +$27.7K |
|
|
AIM
3828
AIM ImmunoTech
AIM
$7.17M
| $753K | ﹤0.01% |
3,733
+212
| +6% | +$42.8K |
|
3829
IRIDEX
IRIX
$14.3M
| $752K | ﹤0.01% |
98,199
| – | – |
|
|
ATCO
3830
DELISTED
Atlas Corp.
ATCO
| $752K | ﹤0.01% |
49,524
+7,112
| +17% | +$102K |
|
3831
Sumitomo Mitsui Financial
SMFG
$167B
| $750K | ﹤0.01% |
107,055
-1,987
| -2% | -$13.8K |
|
3832
Ideal Power
IPWR
$70M
| $749K | ﹤0.01% |
49,259
+10,597
| +27% | +$158K |
|
3833
Mizuho Financial
MFG
$134B
| $748K | ﹤0.01% |
263,708
-19,848
| -7% | -$57.2K |
|
3834
Philips
PHG
$26.8B
| $746K | ﹤0.01% |
20,326
-3,040
| -13% | -$116K |
|
3835
Dolphin Entertainment
DLPN
$15.9M
| $745K | ﹤0.01% |
30,637
| – | – |
|
3836
AYTU BioPharma
AYTU
$24.7M
| $741K | ﹤0.01% |
12,872
+1,800
| +16% | +$135K |
|
3837
Precipio
PRPO
$41.5M
| $737K | ﹤0.01% |
13,081
+3,171
| +32% | +$199K |
|
3838
Alliance Resource Partners
ARLP
$3.2B
| $736K | ﹤0.01% |
67,798
+3,279
| +5% | +$27.3K |
|
3839
Moleculin Biotech
MBRX
$4.06M
| $736K | ﹤0.01% |
655
+21
| +3% | +$24.5K |
|
3840
Travelzoo
TZOO
$74.4M
| $736K | ﹤0.01% |
63,487
+3,138
| +5% | +$39.9K |
|
3841
Aurora
AUR
$13.4B
| $734K | ﹤0.01% |
73,940
| – | – |
|
3842
Voyager Therapeutics
VYGR
$198M
| $732K | ﹤0.01% |
278,646
+520
| +0.2% | +$1.69K |
|
|
PTN
3843
Palatin Technologies
PTN
$17.8M
| $731K | ﹤0.01% |
1,321
| – | – |
|
|
ALR
3844
DELISTED
AlerisLife Inc
ALR
| $730K | ﹤0.01% |
166,747
+1,793
| +1% | +$8.57K |
|
3845
SEACOR Marine Holdings
SMHI
$262M
| $729K | ﹤0.01% |
157,571
-1,297
| -0.8% | -$5.57K |
|
3846
Achieve Life Sciences
ACHV
$744M
| $727K | ﹤0.01% |
85,554
+28,885
| +51% | +$227K |
|
3847
Viper Energy
VNOM
$14.8B
| $727K | ﹤0.01% |
33,309
| – | – |
|
|
SOHU
3848
Sohu.com
SOHU
$364M
| $725K | ﹤0.01% |
34,819
| – | – |
|
|
ELVT
3849
DELISTED
Elevate Credit, Inc.
ELVT
| $722K | ﹤0.01% |
174,900
| – | – |
|
3850
Gencor Industries
GENC
$264M
| $721K | ﹤0.01% |
65,042
-715
| -1% | -$8.26K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.